WASHINGTON--(BUSINESS WIRE)--Today the Partnership to Fight Infectious Disease (PFID), along with the Infectious Diseases Society of America (IDSA), Boomer Esiason Foundation and the Cystic Fibrosis Foundation, unite to highlight the urgency for action on antimicrobial resistance (AMR). An estimated 2.8 million antibiotic-resistant infections occur in the U.S. each year and more than 35,000 people die as a result. Cystic fibrosis is a life-threatening genetic disease that affects more than 30,000 children and adults in the United States. Cystic fibrosis is both serious and progressive; lung damage caused by infection is irreversible and can have a lasting impact on length and quality of life. The Partnership to Fight Infectious Disease (PFID) is a group of patients, providers, community organizations, academic researchers, business and labor groups, and infectious disease experts working to raise awareness of threats posed by infectious disease.

Source: Los Angeles Times May 18, 2022 15:44 UTC